Evidence map›Paper›PMID 36406194›Full record

ArticleWorld journal of oncology2022

Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer.

Yi Xiang, Xiao Juan Lu, Yi Hang Sun, Xia Liu, Yan Yang Wu, Hui Rao, Qiu Yang Que, Qi Xiao, Rui Zhu, Xiao Fei Feng and 7 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Yi XiangDepartment of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
Xiao Juan LuDepartment of Oncology, The People's Hospital of Leshan, Leshan, China.
Yi Hang SunSchool of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Xia LiuDepartment of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
Yan Yang WuFirst Clinical Medical College, Gannan Medical University, Ganzhou, China.
Hui RaoFirst Clinical Medical College, Gannan Medical University, Ganzhou, China.
Qiu Yang QueFirst Clinical Medical College, Gannan Medical University, Ganzhou, China.
Qi XiaoJiangkou Town Central Health Center, Ganzhou, China.
Rui ZhuDepartment of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
Xiao Fei FengDepartment of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
Wei Ling LaiDepartment of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
Xiao Huan ZouDepartment of Critical Care Medicine, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
Ying WangFirst Clinical Medical College, Gannan Medical University, Ganzhou, China.
Song QiuFirst Clinical Medical College, Gannan Medical University, Ganzhou, China.
Li HuangDepartment of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
Hua Qiu ShiDepartment of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
Xiang Cai WangDepartment of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
First Affiliated Hospital of Gannan Medical University · CNGannan Medical University · CNPeople's Hospital of Bishan District · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36406194
PMCPMC9635796
OpenAlexW4307101139

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.